Nasenspray Sine (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By activating alpha receptors on the smooth muscle of nasal blood vessels, it causes vasoconstriction, which decreases mucosal edema and clears nasal passages, providing rapid decongestion.

The appropriate dose of Nasenspray Sine is determined by a qualified prescriber based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but exact instructions should follow the healthcare professional’s recommendation.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nasenspray Sine.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Nasenspray Sine’s active ingredient, Xylometazoline, belongs to the imidazoline class, which provides rapid vasoconstriction similar to phenylephrine‑based sprays. Compared with older agents, Xylometazoline often offers a longer duration of action and may cause less rebound congestion when used within recommended limits.

Store Nasenspray Sine at room temperature, preferably below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nasenspray Sine is applied intranasally. The user tilts the head slightly forward, inserts the nozzle into a nostril, and sprays the prescribed number of sprays while breathing in gently. The same procedure is repeated for the other nostril if required.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, severe hypertension, arrhythmias, nasal ulceration, and rare allergic reactions such as anaphylaxis. If any of these occur, discontinue use and seek immediate medical attention.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation should avoid Nasenspray Sine. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors unless directed by a physician.